# Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site

> **NCT01999153** · PHASE3 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 58 (actual)

## Conditions studied

- Graft Pain

## Interventions

- **DRUG:** 20 mL topically used during alginate dressing NAROPEINE
- **DRUG:** 20 mL topically used during alginate dressing NaCl

## Key facts

- **NCT ID:** NCT01999153
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-09
- **Primary completion:** 2018-10-04
- **Final completion:** 2018-10-04
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999153, "Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01999153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*